Exhaled nitric oxide corresponds with office evaluation of asthma control

Pediatric Pulmonology

Volumn 36, Issue 4, 2003, Pages 283-289

  Meyts, Isabelle ^a   Proesmans, Marijke ^a   De Boeck, Kris ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM; NITRIC OXIDE; STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC VALUE; DISEASE CONTROL; DISEASE MARKER; EVALUATION; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; ONLINE ANALYSIS; PATIENT MONITORING; PRIORITY JOURNAL; RANK SUM TEST; RESPIRATORY TRACT DISEASE; SPIROMETRY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ALBUTEROL; ASTHMA; BREATH TESTS; BRONCHODILATOR AGENTS; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MONITORING, PHYSIOLOGIC; NITRIC OXIDE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 0141631831     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10317     Document Type: Article

References (37)

1. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twenty-man OP, Howarth PH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-457.
2. Holgate ST. The Cournand lecture. Asthma: past, present and future. Eur Respir J 1993;6:1507-1520.
3. Cutz E, Levison EH, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology 1978;2:407-421.
4. Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
5. Nagayama Y, Odazima Y, Nakayama S, Toba T, Funabashi S. Eosinophils and basophilic cells in sputum and nasal smears taken from infants and young children during acute asthma. Pediatr Allergy Immunol 1995;6:204-208.
6. Scheinmann P, Pedersen S, Warner JO, Blic Jd. Methods for assesment of airway inflammation: paediatrics. Eur Respir J 1998;26:53-58.
7. Gaston B, Drazen J, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-551.
8. Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LDK, Wilson AJ, Geller DA, Polak JM. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994;203:209-218.
9. Donnelly LE, Barnes PJ. Expression and regulation of inducible nitric oxide synthase from human primary airway epithelial cells. Am J Respir Cell Mol Biol 2002;26:144-151.
10. Hamid Q, Springall DR, Riveros-MorNO V, Howarth P, Redington A, Bousquet J, Godard P, Holgate ST, Polak JM. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-1513.
11. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368-1370.
12. Artlich A, Hagenah JU, Jonas S. Exhaled nitric oxide in childhood asthma. Eur J Pediatr 1996; 155:698-701.
13. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
14. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:892-896.
15. Baraldi E, Assolin NM, Zanconato S. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997; 131:381-385.
16. Warner JO, Götz M, Landau LI, Levison H, Milner AD, Pedersen S, Silverman M. Management of asthma: a consensus statement. Arch Dis Child 1989;64:1065-1079.
17. Warner JO, Naspitz CK, Cropp GJA. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17.
18. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999. Am J Respir Crit Care Med 1999;160:2104-2117.
19. Bibi H, Montgomery M, Pasterkamp H, Chernick V. Relationship between response to inhaled salbutamol and metacholine bronchial provocation in children with suspected asthma. Pediatr Pulmonol 1991;10:244-248.
20. American Thoracic Society. ATS statement. Snowbird Workshop on Standardization of Spirometry. Am Rev Respir Dis 1979; 119:831-838.
21. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. Basel: Karger Verlag; 1987.
22. Piacentini GL, Bodini A, Costella S, Vicentini L, Mazzi P, Suzuki Y, Peroni D, Boner AL. Exhaled nitric oxide in asthmatic children exposed to relevant allergans: effect of flunisolide. Eur Respir J 2000;15:730-734.
23. Colon-Semidey AJ, Marshik P, Crowley M, Katz R, Kelly HW. Correlation between reversibility - of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatr Pulmonol 2000;30:385-392.
24. Griese M, Koch M, Latzin P, Beck J. Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. Eur J Med Res 2000;5:334-340.
25. ERS Task Force. Difficult/therapy resistant asthma. Eur Respir J 1999; 13:1198-1208.
26. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticason in children with persistent asthma. Pharmacotherapy 2001;21:1464-1467.
27. Bender BG, Wamboldt FS, O'Connell SL, Rand C, Szefler S, Milgrom H, Wamboldt MZ. Measurement of children's asthma medication adherence by self report, mother report, canister weight and Doser CT. Ann Allergy Asthma Immunol 2000;85:416-421.
28. Bender BG. Overcoming barriers to non-adherence in asthma treatment. J Allergy Clin Immunol 2002;109:554-559.
29. Artlich A, Busch T, Lewandowski K, Jonas S, Gortner L, Falke KJ. Childhood asthma: exhaled nitric oxide in relation to clinical symptoms. Eur Respir J 1999; 13:1396-1401.
30. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996;9:196-201.
31. Silvestri M, Spallarossa D, Yourukova VF, Battistini E, Fregonese B, Rossi GA. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma. Eur Respir J 1999;13:321-326.
32. Piacentini GL, Bodini A, Costella S, Vincentini L, Mazzi P, Speriandio S, Boner AL. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999;13:1386-1390.
33. Baraldi E, Carra S, Dario C, Azzolin N, Ongaro R, Marcer G, Zacchello F. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med 1999;159:262-266.
34. Van der Toorn LM, Prins J-B, Overbeek SE, Hoogsteden HC, de Jongste JC. Adolescents in clinical remission of atopic asthma have elevated eNO levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162:953-957.
35. de Kluijver J, Evertse CE, Schrumpf JA, van der Veen H, Zwinderman AH, Hiemstra PS, Rabe KF, Sterk PJ. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma. Am J Respir Crit Care Med 2002;166:294-300.
36. Jones S, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, Taylor RD. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-743.
37. Baraldi E, de Jongste J, ERS Task Force. Measurement of exhalednitric oxide in children, 2001. Eur Respir J 2002;20:223-237.